简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2022-06-13 09:22 Galderma Announces Positive Results in Two Phase III Studies for a Novel Liquid Formulation botulinumtoxinA (RelabotulinumtoxinA) for the Treatment of Glabellar Lines (frown) and Lateral Canthal Lines (crow’s Feet)
2022-06-10 16:20 Ferring Announces New Collaboration for Development of Olamkicept
2022-06-10 15:58 Takeda’s Dengue Vaccine Candidate Provides Continued Protection Against Dengue Fever Through 4.5 Years in Pivotal Clinical Trial
2022-06-09 10:40 Exscientia to Present at the Goldman Sachs 43rd Annual Global Healthcare Conference
2022-06-08 15:18 Galderma to Present New Findings From Innovative Product Portfolio at the 2022 VCS Annual Symposium
2022-06-08 09:33 mAbxience Continues Manufacturing Capacity Expansion with ABEC Single-Use Bioreactor Technology
2022-06-06 19:12 On One Year Anniversary, Organon Introduces Global ESG Strategy and Commitments with Publication of Inaugural ESG Report
2022-06-06 17:21 Rapid Medical Enrolls the First Patient in the DISTALS Stroke Trial–Offering Treatment to New Ischemic Stroke Patient Population
2022-06-06 09:32 Merck Advances Development Programs in Oncology Focusing on Novel Mechanisms and Pathways
2022-06-06 09:29 BOEHRINGER INGELHEIM ENTERS GLOBAL LICENSING AGREEMENT TO DEVELOP AND COMMERCIALIZE INNOVATIVE ANTIBODIES FROM A*STAR FOR TARGETED CANCER THERAPIES
2022-06-02 18:35 Transphorm’s GaN FETs Enable High Reliability Medical Applications: LEMURIA Li-ion Battery Power Supply from Nayuta
2022-06-01 17:23 Takeda Presents Latest Research from Oncology Portfolio and Pipeline at ASCO & EHA
2022-06-01 13:47 Takeda and Moderna Announce Plans to Transfer Marketing Authorization for Spikevax™ COVID-19 Vaccine in Japan to Moderna
2022-06-01 12:04 Galderma to Present Extensive New Clinical Data Across Its Portfolio of Neuromodulators, Fillers and Biostimulators at the IMCAS World Congress 2022d Biostimulators at the IMCAS World Congress 2022
2022-05-30 16:56 Takeda and Seagen to Highlight ADCETRIS® Combination Data Showing Statistically Significant Improvement in Overall Survival (OS) for Patients with Advanced Hodgkin Lymphoma
2022-05-30 10:02 LintonPharm to Release Data on Catumaxomab for Advanced Gastric Cancer with Peritoneal Metastasis at 2022 ASCO Annual Meeting
2022-05-27 19:03 IntelliCentrics’ Innovations Help Drive Advanced Dallas Hospital & Clinics’ Mission of Delivering Leading Edge Medicine and Personalized Patient Care
2022-05-27 16:56 Medisca Drives Worldwide Access to Thyroid through Distribution License with SUANFARMA
2022-05-27 13:59 Exscientia Business Update for First Quarter 2022
2022-05-27 11:02 Ferring Presents New Analyses of Efficacy, Safety and Microbiome Composition Data at DDW 2022 for RBX2660 its Investigational Microbiota-Based Live Biotherapeutic

Business Wire Weibo

Press Releases

Latest Releases